160 related articles for article (PubMed ID: 32000385)
1. Association between C-reactive protein level and subsequent risk of ovarian cancer: A meta-analysis of 13 cohorts in 1,852 ovarian cancer patients.
Wang Y; Zhang Z; Wang J; Zhang X
Medicine (Baltimore); 2020 Jan; 99(5):e18821. PubMed ID: 32000385
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysis.
Zhang W; Zhang Z; Qian L
World J Surg Oncol; 2024 Jan; 22(1):8. PubMed ID: 38172843
[TBL] [Abstract][Full Text] [Related]
4. High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium.
Peres LC; Mallen AR; Townsend MK; Poole EM; Trabert B; Allen NE; Arslan AA; Dossus L; Fortner RT; Gram IT; Hartge P; Idahl A; Kaaks R; Kvaskoff M; Magliocco AM; Merritt MA; Quirós JR; Tjonneland A; Trichopoulou A; Tumino R; van Gils CH; Visvanathan K; Wentzensen N; Zeleniuch-Jacquotte A; Tworoger SS
Cancer Res; 2019 Oct; 79(20):5442-5451. PubMed ID: 31462430
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus and risk of ovarian cancer. A systematic review and meta-analysis of 15 cohort studies.
Zhang D; Li N; Xi Y; Zhao Y; Wang T
Diabetes Res Clin Pract; 2017 Aug; 130():43-52. PubMed ID: 28554142
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein and risk of ovarian cancer: A systematic review and meta-analysis.
Li J; Jiao X; Yuan Z; Qiu H; Guo R
Medicine (Baltimore); 2017 Aug; 96(34):e7822. PubMed ID: 28834887
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
8. Alcohol drinking and epithelial ovarian cancer risk. a systematic review and meta-analysis.
Rota M; Pasquali E; Scotti L; Pelucchi C; Tramacere I; Islami F; Negri E; Boffetta P; Bellocco R; Corrao G; La Vecchia C; Bagnardi V
Gynecol Oncol; 2012 Jun; 125(3):758-63. PubMed ID: 22449732
[TBL] [Abstract][Full Text] [Related]
9. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis.
Li Y; Zhong X; Cheng G; Zhao C; Zhang L; Hong Y; Wan Q; He R; Wang Z
Atherosclerosis; 2017 Apr; 259():75-82. PubMed ID: 28327451
[TBL] [Abstract][Full Text] [Related]
10. Hs-CRP in stroke: A meta-analysis.
Zhou Y; Han W; Gong D; Man C; Fan Y
Clin Chim Acta; 2016 Jan; 453():21-7. PubMed ID: 26633855
[TBL] [Abstract][Full Text] [Related]
11. Infertility and ovarian cancer risk: Evidence from nine prospective cohort studies.
Jiang YT; Gong TT; Zhang JY; Li XQ; Gao S; Zhao YH; Wu QJ
Int J Cancer; 2020 Oct; 147(8):2121-2130. PubMed ID: 32285933
[TBL] [Abstract][Full Text] [Related]
12. Recreational physical activity and risk of ovarian cancer: a meta-analysis.
Zhou LM
Asian Pac J Cancer Prev; 2014; 15(13):5161-6. PubMed ID: 25040968
[TBL] [Abstract][Full Text] [Related]
13. Hysterectomy and risk of ovarian cancer: a systematic review and meta-analysis.
Huo X; Yao L; Han X; Li W; Liu J; Zhou L; Gou Y; Yang K; Liu H
Arch Gynecol Obstet; 2019 Mar; 299(3):599-607. PubMed ID: 30607584
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
15. Dose-risk relationships between cigarette smoking and ovarian cancer histotypes: a comprehensive meta-analysis.
Santucci C; Bosetti C; Peveri G; Liu X; Bagnardi V; Specchia C; Gallus S; Lugo A
Cancer Causes Control; 2019 Sep; 30(9):1023-1032. PubMed ID: 31236793
[TBL] [Abstract][Full Text] [Related]
16. Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis.
Ye Q; Cheng J; Ye M; Liu D; Zhang Y
J Gynecol Oncol; 2019 Jan; 30(1):e5. PubMed ID: 30479089
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein and risk of fracture: a systematic review and dose-response meta-analysis of prospective cohort studies.
Wu ZJ; He JL; Wei RQ; Liu B; Lin X; Guan J; Lan YB
Osteoporos Int; 2015 Jan; 26(1):49-57. PubMed ID: 25107320
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus and the risk of ovarian cancer: a systematic review and meta-analysis of cohort and case-control studies.
Wang L; Zhong L; Xu B; Chen M; Huang H
BMJ Open; 2020 Dec; 10(12):e040137. PubMed ID: 33376163
[TBL] [Abstract][Full Text] [Related]
19. Linear reduction in thyroid cancer risk by oral contraceptive use: a dose-response meta-analysis of prospective cohort studies.
Wu L; Zhu J
Hum Reprod; 2015 Sep; 30(9):2234-40. PubMed ID: 26141711
[TBL] [Abstract][Full Text] [Related]
20. Tea consumption and the risk of ovarian cancer: A meta-analysis of epidemiological studies.
Zhan X; Wang J; Pan S; Lu C
Oncotarget; 2017 Jun; 8(23):37796-37806. PubMed ID: 28445129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
